Tanshinone ameliorates mitochondrial dysfunction in chronic obstructive pulmonary disease via PRTN3-mediated regulation of the HIF-1α/BNIP3 signaling pathway.
文献摘要
Objective Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition characterized by persistent airflow limitation and chronic inflammation. This study aimed to investigate whether a tanshinone multi-component mixture (TS) ameliorates mitochondrial dysfunction in COPD by regulating the hypoxia-inducible factor 1-alpha (HIF-1α)/BCL2-interacting protein 3 (BNIP3) signaling pathway via proteinase 3 (PRTN3). Methods A COPD mouse model was established through cigarette smoke (CS) exposure combined with intranasal lipopolysaccharide (LPS) instillation, and the effects of TS on pulmonary function, inflammatory infiltration, and histopathology were evaluated. Bioinformatics analysis was performed using the GSE278206 dataset. A coculture system of 16HBE cells and differentiated HL-60 (dHL-60) cells was constructed to mimic the COPD airway microenvironment. qRT-PCR, Western blotting, ELISA, JC-1 staining, MitoSOX staining, and confocal microscopy were used to assess PRTN3, the HIF-1α/BNIP3 pathway, and mitochondrial function parameters. Rescue experiments were performed using exogenous rh-PRTN3, the neutrophil serine protease inhibitor sivelestat, and cobalt chloride (CoCl₂), a HIF-1α activator, to verify the underlying mechanism. Results TS treatment significantly ameliorated pulmonary function impairment, reduced inflammatory infiltration, and attenuated structural damage in the lung tissues of COPD mice. PRTN3 was significantly upregulated in COPD lung tissues. TS effectively inhibited the abnormally elevated expression and secretion of PRTN3 in the COPD microenvironment both in vivo and in vitro. By inhibiting PRTN3, TS blocked excessive activation of the HIF-1α/BNIP3 pathway, decreased the LC3B-II/LC3B-I ratio and Beclin-1 expression, restored mitochondrial membrane potential, and reduced mt-ROS accumulation. Exogenous rh-PRTN3 or the HIF-1α activator CoCl₂ significantly reversed the protective effects of TS, whereas sivelestat further enhanced the protective effects of TS. Conclusion This study is the first to demonstrate that TS ameliorates COPD by inhibiting PRTN3, thereby blocking HIF-1α/BNIP3-mediated excessive mitophagy and restoring mitochondrial homeostasis. PRTN3 may serve as a biomarker and therapeutic target for neutrophilic inflammation in COPD.